Sarah Cannon is a global leader in cancer research and has been serving patients in the community for more than 25 years. We offer physicians and their patients access to a robust trial menu that investigates more than 200+ unique agents through trials each year. As trusted experts in the field of oncology research, Sarah Cannon has conducted more than 300 first-in-man trials to date and been a clinical trial leader in the majority of approved cancer therapies over the last decade.

New trials open regularly and availability may change, so please email asksarah@sarahcannon.com and one of our askSARAH representatives can assist you.

OR